Camena Bioscience appoints Dr Nicola Thompson as Chair of the Board

Cambridge, UK: Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, announces it has appointed Dr Nicola Thompson as Chair of its Board of Directors. Following its $10 million Series A financing earlier in the year1, the appointment forms part of the Company’s growth plans to expand commercialisation of its pioneering DNA synthesis…

Evonetix announces agreement for revolutionary Gene Synthesis Platform with Analog Devices

Cambridge, UK, 06 December 2023 – EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, announces the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc. (ADI), a global semiconductor leader. This agreement signals the continuation of the long-standing combined work of both companies,…

Meet Helena Ahlfors, our new Head of Research Data and Technology at the BioResource

Find out more about Helena, including why she chose to work at the BioResource, her hobbies, and the best book she's ever read!

Making AI work for you: 6 tips to future-proof your career

Career Ambitions writes...How do you feel about the rapid development in AI? Fascinated? Terrified? Maybe a little bit of both? Whilst the possibilities it offers are undoubtedly exciting, the alarming predictions in the media about how AI could kill certain jobs, has left many of us feeling anxious about how our future careers will look in an AI world.

International Day of Persons with Disabilities 2023 & reflection on our work with Purple Goat

In celebration of the International Day of Persons with Disabilities 2023 and Disability History Month, the BioResource would like to share some of the Diversity, Equity and Inclusion work we have been doing via our partnership with the inclusive marketing agency, Purple Goat.

Inward investment service attracts health tech pioneer to set up its global HQ in Cambridgeshire

An Australian-founded health tech company opened its global HQ in Cambridgeshire due to the support provided by the Combined Authority’s dedicated inward investment service branded as Locate Cambridge.

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

Arecor signs co-development and exclusive licence option agreement with leading global medical products company for in-house speciality hospital product

Arecor-developed, Arestat™-enabled product is potentially first ready-to-dilute liquid formulation of a high-value oncology therapy

Double your donation with the Big Give

Tom’s Trust is joining forces with the Big Give again this year to double supporters’ donations and launch its Christmas campaign for 2023. The campaign, ‘Donate Your Last Hour’, encourages the charity’s supporters to donate their last hour of wages in 2023, which will then be 

Sound installation tells of highs and lows of life in NHS

Visitors to Addenbrooke’s Treatment Centre (ATC) will be able to listen to a unique sound installation from Monday 4 to 8 December that gives a compelling insight into life behind hospital doors.

Arecor continues collaboration with Lilly

Development of an enhanced formulation of Lilly proprietary product using Arecor’s formulation technology platform Arestat™

Clinical considerations & payer perspectives

Late October saw the annual gathering of oncologists and industry in Madrid for ESMO 2023, bringing with it a wave of new clinical results across cancers and a fresh round of questions concerning pricing, access and reimbursement.

Redundancy: A Golden-Ticket Opportunity

Providing support and strategies for individuals whose roles were made redundant in the Biopharma, Medical Devices, and Health Tech industries

Matrix Bio, a Cambridge based biotech startup wins the o2h tech kickstarter 2.0 competition

Cambridge, UK: We are thrilled to announce the first winner of the tech Kickstarter 2.0 Competition – Matrix Bio! Based in Cambridge, Matrix Bio is an early-stage tech bio startup developing disruptive digital platforms to transform how researchers design and optimize hydrogels.

5 key considerations in connected device development

The value of a well-managed connected device can be significant, to both individuals and businesses.

PlaqueTec recruits first ten patients in BIOPATTERN trial

Cambridge, UK: PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), announces that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.

Are employers responsible for the sick leave of workers they've sponsored?

Immigration lawyer Julie Moktadir says the demands of the health and care sector often sees employers asking questions in respect of sponsored workers.

Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema

Cambridgeshire and Nottingham, UK, 28 November 2023: Exonate Ltd., an mRNA therapy company focused on treatments for diabetic complications, announces its lead ophthalmology asset, EXN407, has achieved its prespecified endpoints in a phase Ib/IIa study.

UK falling behind rest of the world on realising value from new technology - Deloitte

New research from Deloitte reveals the top barriers to implementing and monetising digital technologies such as Cloud, AI and machine learning; Three-quarters of UK organisations believe that digital transformation is the single most important investment they can make; But, 30% of UK organisations lack a transformation strategy, while nearly a third lack understanding of new technology.

Still time for agri and food-tech businesses to apply for innovation grants of up to £300,000

There is still time for businesses in the agri-tech, agri-biotech and food-tech sectors to apply for grants and support to boost innovation and growth.

Strategies for combination therapy in oncology: Part two - Working with the “status quo”

This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe.

Source Genomics White Paper explores the transformative power of multi-omics in genomic research

Multiomics combines the various ‘omics disciplines that make up the complex landscape of life science research.

Prologis UK announces letting of prime lab space at Europe’s leading life sciences hub

Prologis UK, a leading property developer, investor and owner, has secured a 15-year lease from Cambridge University Hospitals NHS Foundation Trust (CUHT) for the top floor of its newly developed, state-of-the-art life sciences facility at Cambridge Biomedical Campus (CBC).

Celebrating our Centres - Moorfields

This week, we hear from our colleagues at the NIHR BioResource Centre Moorfields in London about their rare and common eye disorders research. We also celebrate examples of recent progress and find out about the outcomes from a successful patient and public co-development project.

Brilliant impulse alumni continue to dazzle as application window for 2024 programme opens

ALUMNI of University of Cambridge’s hugely successful entrepreneurship and intrapreneurship programme, impulse continue to shine as the application window for the new 2024 intake opens.